Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt
29 January 2026
1 min read

Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt

NEW YORK, Jan 29, 2026, 09:38 EST — Regular session

  • Tesla shares barely moved in early trading, following swings triggered by earnings and spending plans.
  • Investors are balancing Tesla’s move into robotaxis and robotics with a weaker core EV market.
  • Attention is turning to cash burn, regulatory challenges, and upcoming rollout targets.

Tesla shares edged up 0.07% to $431.46 in early Thursday trading, following a close of $431.16 the previous day.

The stock’s recent jump comes amid a flurry of headlines: a new investment linked to Elon Musk’s AI goals, plus a steep increase in planned expenditures.

Here’s why it matters now: Tesla’s market value hinges largely on its bets on autonomy and robotics. That’s despite growing challenges in its car segment, where demand is cooling, prices are under pressure, and rivals are closing in.

Tesla announced a roughly $2 billion investment in xAI, the AI firm started by Musk, while reaffirming that its Cybercab robotaxi production remains on schedule. Thomas Monteiro, senior analyst at Investing.com, described Tesla as “entering a transition phase,” noting that “rollout metrics” now carry more weight than vehicle delivery numbers. 1

During the earnings call, Tesla’s ramped-up spending plans stood out. Musk described it as “a very big capex year,” referring to capital expenditures—funds allocated to factories and equipment—as the company expands production lines for the Cybercab, the Optimus humanoid robot, and other ventures. Scott Acheychek, COO of REX Financial, pointed to a “business model transition now underway” as the bigger story. 2

The steep rise in spending dampened the early rally. Tesla shares gained roughly 3.5% in after-hours trading following the earnings release, only to pull back as investors weighed the costs. On Thursday, Tesla’s shares listed in Frankfurt climbed 1.8%. 3

Tesla filed its annual report and an 8-K on Wednesday, company documents reveal, offering investors fresh details on the AI initiatives and financing strategy. 4

There’s still plenty that could derail progress. Regulators haven’t approved fully driverless cars for wide use, and Tesla is wagering big on tech that hasn’t been tested at scale. Missed deadlines or a sudden need for more funding could easily weigh on the stock again.

Tesla’s next milestones are near. In its quarterly update, the company reported 2025 revenue dipped 3% to $94.83 billion. It closed the year with $44.06 billion in cash, cash equivalents, and investments. Tesla expects its xAI investment to wrap up in Q1 2026 and plans to launch a Gen 3 Optimus in the same quarter. Production for Cybercab and Tesla Semi is set to start in the first half of 2026. 5

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Amazon stock slips after 16,000-job cut plan as Wall Street eyes Feb. 5 results
Previous Story

Amazon stock slips after 16,000-job cut plan as Wall Street eyes Feb. 5 results

Denison Mines stock (DNN) rises in premarket after uranium jumps back above $100
Next Story

Denison Mines stock (DNN) rises in premarket after uranium jumps back above $100

Go toTop